IDRA Stock Price Increases Over 20% Pre-Market: Why It Happened

By Amit Chowdhry ● June 22, 2021
  • The stock price of Idera Pharmaceuticals Inc (NASDAQ: IDRA) increased by over 20% pre-market. This is why it happened.

The stock price of Idera Pharmaceuticals Inc (NASDAQ: IDRA) increased by over 20% pre-market. Investors are responding positively to an SEC filing. 

The SEC filing shows that Idera Pharmaceuticals chief operating officer Daniel Soland bought a large position in the company. Specifically, Soland bought 50,000 shares at $1.19, bringing the number of securities owned by him to 78,843. 

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.